Clik here to view.
Zinc and Copper Metabolic Cycles in Baby Teeth Linked to Autism
Mount Sinai Research Could Result in Early Diagnostic System for Autism Spectrum Disorder Using evidence found in baby teeth, researchers from the Institute for Exposomic Research at the Icahn School...
View ArticleWATCH: Autism, ALS, and other Complex Neurological Disorders: Understanding...
Webinar by: Manish Arora, BDS, MPH, PhD, FICD, Edith J. Baerwald Professor and Vice Chair, Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai.Dr. Arora discusses how...
View ArticleClik here to view.
Mount Sinai Spin-Off Company, Linus Biotechnology Inc., to Revolutionize...
The new company will develop a technology platform that will build on breakthroughs in exposome sequencing by Drs. Manish Arora, Christine Austin and Paul Curtin of the Institute for Exposomic...
View ArticleClik here to view.
Mount Sinai Spin-Off Company, Linus Biotechnology Inc., Receives FDA...
StrandDx- ASD Exposome Sequencing Diagnostic was developed based on technology developed by Dr. Manish Arora, Christine Austin and Paul Curtin of the Institute for Exposomic Research at Mount Sinai....
View ArticleClik here to view.
Harnessing the ‘Exposome’ to Diagnose Autism
In an interview with Spectrum, Dr. Manish Arora, director of The Mount Sinai Institute for Exposomic Research labs and Co-founder of ‘Linus Biotechnology’, described what is next for the company’s...
View ArticleClik here to view.
WATCH: Detecting autism at birth and opportunity for early intervention
Webinar by: Dr. Manish Arora Manish Arora, BDS, MPH, PhD, Edith J. Baerwald Professor and Vice Chairman of the Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount...
View ArticleClik here to view.
WATCH: Exposomics and Autism
Autism prevalence has been rising steadily since the 1990s but despite extensive research, a genetic cause has not been identified. Experts from the Mount Sinai Institute for Exposomic Research...
View ArticleClik here to view.
Mount Sinai Spinoff Startup LinusBio Raises $16 Million in Series A funding
The company is developing an early autism detection and treatment platform LinusBio, a 2021 spinoff company from Mount Sinai, announced it raised over $16 million in Series A venture capital funding...
View Article
